BORTECAD BORTEZOMIB INJECTION

Get a Price/Quote

MOQ : 1 Bottle

BORTECAD BORTEZOMIB INJECTION Specification

Pacakaging (Quantity Per Box)
1 vial per box

Origin of Medicine
Imported

Salt Composition
Bortezomib

Indication
Multiple Myeloma, Mantle Cell Lymphoma

Dosage Form
Injection

Drug Type
Allopathic

Ingredients
Bortezomib

Physical Form
Liquid

Function
Anti-Cancer

Recommended For
As directed by physician

Dosage
As prescribed by physician

Dosage Guidelines
Follow healthcare providers instructions

Suitable For
Adults

Quantity
1 Vial

Storage Instructions
Store below 25C. Protect from light.

BORTECAD BORTEZOMIB INJECTION Trade Information

Minimum Order Quantity
1 Bottle

Packaging Details
PACK OF 1 VIAL

About BORTECAD BORTEZOMIB INJECTION

PRODUCT DETAILS

BRAND NAME: BORTECAD

CONTENT: BORTEZOMIB

STRENGTH: 2MG

PACKAGING: PACK OF 1 VIAL

MANUFACTURED BY: CADILA

Note:-Bortecad Is APrescription Drug And Should Be Used Under Proper Medical Guidance And Advice.Do Not Share The Medicine With Others, Since They May Be Suffering From AProblem That Is Not Effectively Treated By This Drug.............

Precisely Formulated Anti-Cancer Therapy

Bortecad is formulated with bortezomib, a potent anti-cancer agent. It is particularly effective in managing multiple myeloma and mantle cell lymphoma, offering targeted action against malignant cells. As an allopathic injection, it acts directly through the bloodstream, allowing for rapid therapeutic response.

Safe Administration and Usage Guidelines

This medication is available only under prescription and should be administered intravenously or subcutaneously by medical professionals. Dosage and treatment duration are tailored to each patient by the physician. Following healthcare provider instructions is critical to ensure optimal efficacy and minimize risks.

Storage and Handling Precautions

Bortecad requires careful storage below 25C, protected from direct light to preserve its stability and effectiveness. Always keep the packaging intact until use and handle with medical supervision. The recommended shelf life ensures potency for up to two years from manufacturing.

FAQs of BORTECAD BORTEZOMIB INJECTION:

Q: How is Bortecad (Bortezomib Injection) administered?

A: Bortecad is administered either intravenously or subcutaneously by a healthcare professional in a clinical setting. The exact route and dosage depend on the patients specific medical condition and physicians instructions.

Q: What conditions is Bortecad recommended for?

A: Bortecad is primarily indicated for the treatment of multiple myeloma and mantle cell lymphoma. Its anti-cancer properties make it suitable for targeting malignant cells in these conditions.

Q: When should Bortecad be used during treatment?

A: Bortecad should be used as part of a prescribed anti-cancer regimen and only under strict medical supervision. The timing and duration of treatment are determined by the physician based on individual patient needs.

Q: Where should Bortecad be stored before administration?

A: Bortecad must be stored below 25C in a cool, dark place, away from direct sunlight. Maintaining recommended conditions ensures the injections stability and potency until use.

Q: What is the process for using Bortecad safely?

A: This medication should always be prepared and administered by qualified healthcare providers. Patients must follow dosage and scheduling instructions precisely, as directed by their physician, to reduce risks and maximize therapeutic benefit.

Q: What are the benefits of Bortecad in cancer therapy?

A: Bortecad delivers targeted anti-cancer effects, helping manage and treat multiple myeloma and mantle cell lymphoma. It contributes to reducing cancer cell proliferation and may improve overall patient outcomes when used as part of a comprehensive treatment plan.

Tell us about your requirement